Frank David
Advertisement
Articles by Frank David
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Spyre’s Anti-TL1A Antibody SPY072 Misses in Psoriatic Arthritis and Axial Spondyloarthritis, Shifts Focus to Hidradenitis Suppurativa
2
The BioPharm Brief: A Bispecific Approval in Head and Neck Cancer, TCR Bispecifics Head to the Clinic, and a New Antibody Target in Essential Thrombocythemia
3
Amgen Real-World Study Links Evolocumab to Lower Heart Attack Risk Than Ezetimibe
4
Alethio Raises $90 Million to Advance First-in-Class G6B Antibody for Essential Thrombocythemia
5